• About
    • Our Team
    • Clinical Advisory Board
    • Board of Directors
  • Product
  • Investors & Partners
  • News
  • Contact

News

Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes

November 2, 2020 by zucaraadmin

Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes – ZT-01 Development for T2D to be Supported by Nearly

read more

Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01

September 29, 2020 by zucaraadmin

Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01 – Phase 1 Trial to Evaluate ZT-01 for the

read more

Zucara Therapeutics Announces US$21 Million Series A Financing

March 31, 2020 by zucaraadmin

Zucara Therapeutics Announces US$21 Million Series A Financing – Proceeds to Fund Development of ZT-01 Through Phase 2 Clinical Trials

read more

Zucara Therapeutics Presents New Data at European Association for the Study of Diabetes

September 19, 2019 by zucarastaff

Dr. Richard Liggins, Chief Scientific Officer, presenting at EASD in Barcelona. TORONTO, Canada and BARCELONA, Spain: Zucara Therapeutics Inc., a

read more

Zucara Therapeutics Secures Grant from GlycoNet to Expand and Validate their Drug Therapy Model for Type 1 Diabetes to Type 2 Diabetes

July 12, 2019 by zucarastaff

Toronto & Vancouver, Canada:  Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in

read more

Remembering Dr. Mladen Vranic: The Outstanding Diabetes Researcher

June 24, 2019 by zucarastaff

(Michael Midmer & Dr. Mladen Vranic) Dr. Mladen Vranic, a leading scientist and advocate for the advancement of diabetes research,

read more

Zucara Therapeutics Adds Additional Drug Development Executives to its Board of Directors

May 14, 2019 by zucarastaff

TORONTO, Canada: Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in people with

read more

Susan Peers Joins Zucara’s Leadership Team

March 13, 2019 by zucarastaff

Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in people with Type 1

read more

Zucara Therapeutics – Helping people with diabetes sleep safely and soundly

November 14, 2018 by zucarastaff

Typically occurring overnight, hypoglycemia puts over 8 million people with diabetes at fatal risk during their sleep. Current therapies offer

read more

Zucara Therapeutics Secures US$3.9M from the Helmsley Charitable Trust to Advance Diabetes Drug Candidate to Clinical Trials

April 9, 2018 by zucarastaff

Toronto and Vancouver, Canada: Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once-daily therapeutic to prevent low blood

read more
  • 1
  • 2
  • 3
  • Next Page»

OUR PARTNERS






CATEGORIES

  • News

Copyright 2021 Zucara Therapeutics, all rights reserved.